Pinprick blood test could detect disease 10 years before symptoms appear, study finds

A recent study suggests that electroconvulsive therapy (ECT) may lead to a broader range of adverse effects than previously recognized, prompting calls for a suspension of its use until further research is conducted. While memory loss is a known consequence of ECT, researchers identified 25 additional concerning side effects, including cardiovascular issues, fatigue, and emotional blunting.

A new drug, Sorfequiline, has shown promising results in trials for treating tuberculosis (TB), potentially increasing cure rates and reducing treatment duration. Last year, TB affected an estimated 10.7 million people globally, leading to 1.23 million deaths.